Blood-based DNA methylation marker model for short-term and long-term lung cancer risk prediction - Quiz - MDSpire

Blood-based DNA methylation marker model for short-term and long-term lung cancer risk prediction

  • By

  • Megha Bhardwaj

  • Yi-Qian Sun

  • Clara Frick

  • Ben Schöttker

  • Oluf Dimitri Røe

  • Bernd Holleczek

  • Xiao-Mei Mai

  • Hermann Brenner

  • June 6, 2026

  • 0 min

Share

Original Source(s)

Blood-based DNA methylation marker model for short-term and long-term lung cancer risk prediction

  • by Megha Bhardwaj, Yi-Qian Sun, Clara Frick, Ben Schöttker, Oluf Dimitri Røe, Bernd Holleczek, Xiao-Mei Mai, Hermann Brenner

  • June 6, 2026

Related Content

Wearable technologies for perioperative recovery monitoring in lung cancer surgery: a systematic review of feasibility, recovery outcomes, and evidence certainty

Case Report: Successful conversion surgery following chemo-antiangiogenic therapy in a lung adenocarcinoma patient with active rheumatoid arthritis and rare EGFR mutation after immunotherapy-triggered flare

Dynamic consent framework for low-dose CT scan lung cancer screening: autonomy, privacy, ethical data management